Target intelligence / Profile preview

Extracellular matrix proteins and soluble basic proteins

Molecular classification
Extracellular matrix protein, Growth factor, Cytokine, Other
01

Overview

The Extracellular matrix proteins and soluble basic proteins category encompasses a wide array of structural and signaling molecules located in the interstitial space. Extracellular matrix (ECM) proteins, including collagen and fibronectin, provide the physical framework for tissues and modulate cell adhesion and migration [2]. Soluble basic proteins often include essential growth factors like Fibroblast Growth Factor (FGF) and Platelet-Derived Growth Factor (PDGF), which carry a positive charge at physiological pH [3]. These proteins are critical in regulating physiological processes such as wound healing, angiogenesis, and tissue remodeling. In pathological states like cancer, these proteins are often overexpressed or remodeled to support tumor growth and metastasis [1]. This broad group is targeted by polyanionic drugs, most notably suramin, which binds to the basic domains of these proteins via electrostatic interactions [1]. By sequestering these factors, such drugs prevent them from activating their respective cell-surface receptors, thereby inhibiting proliferative signaling. However, the lack of specificity inherent in targeting such a broad class of proteins leads to significant therapeutic challenges, including systemic toxicity and varied off-target effects.

Other names
ECM proteinsHeparin-binding proteinsBasic growth factorsPolyanion-binding proteins
02

Mechanism of action

Competitive inhibition of growth factor-receptor binding through electrostatic sequestration of basic protein domains by polyanionic compounds.

03

Biological functions

Cell adhesionSignal transductionAngiogenesisTissue remodelingStructural integrity
04

Disease associations

CancerTrypanosomiasisOnchocerciasisFibrosisInflammation
05

Safety considerations

CoagulopathyNephrotoxicityAdrenal insufficiencyNon-specific systemic toxicityOff-target effects
06

Interacting drugs

Suramin

2 more in the full profile.

Beyond the preview

Go deeper on Extracellular matrix proteins and soluble basic proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix proteins and soluble basic proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call